Results 201 to 210 of about 5,333,057 (253)

Prevalence of extracranial carotid artery disease in symptomatic peripheral artery disease and implications for long-term outcome. [PDF]

open access: yesAnn Med
Zierfuss B   +9 more
europepmc   +1 more source

Clinical Value and Research Prospects of 1024 Matrix Optimization in 64‐Slice Cerebral CTA for Perforating Artery Visualisation

open access: yesJournal of Medical Radiation Sciences, EarlyView.
This letter comments on Nagumo et al.'s study evaluating 1024‐matrix reconstruction for intracranial perforating artery visualisation in 64‐slice cerebral CTA, affirming its cost‐effective value for standard CT scanners (https://doi.org/10.1002/jmrs.70055).
Yang Liu, Wei Wu
wiley   +1 more source

Neuroprotective effects of quercetin in animal models of neurodegenerative diseases: A systematic review and meta‐analysis

open access: yesJournal of the Science of Food and Agriculture, EarlyView.
Abstract Neurodegenerative conditions such as Alzheimer's disease and Parkinson's disease are characterized by progressive neuronal loss driven by oxidative stress and inflammation. Quercetin, a dietary flavonoid with established antioxidant and anti‐inflammatory properties, has emerged as a potential neuroprotective agent.
In Ho Cho   +6 more
wiley   +1 more source

A Standardized Technique for Ultrasound–MRI Fusion Imaging of the Carotid Artery for Vascular Assessment

open access: yesJournal of Ultrasound in Medicine, EarlyView.
Purpose To describe a reproducible ultrasound–magnetic resonance imaging (MRI) fusion imaging technique developed for quantitative assessment of carotid wall strain and plaque morphology. Methods MRI volumes (Oblique T2 Cube) were imported into the Sequoia ultrasound system equipped with an electromagnetic tracking module.
Maxwell J. Kiernan   +10 more
wiley   +1 more source

Super Learner Algorithm for Carotid Artery Disease Diagnosis: A Machine Learning Approach Leveraging Craniocervical CT Angiography. [PDF]

open access: yesTomography
Özdemir Hİ   +8 more
europepmc   +1 more source

Long‐Term Clinical Response After Low‐Dose and Short‐Duration Cemiplimab Therapy in a Patient With Xeroderma Pigmentosum in Nepal

open access: yesJEADV Clinical Practice, EarlyView.
Capsule Summary Xeroderma pigmentosum (XP) is associated with a high risk of multiple and aggressive cutaneous squamous cell carcinomas (CSCCs). The immune checkpoint inhibitor cemiplimab has been approved in advanced, unresectable, and/or metastatic CSCCs.
Sudip Parajuli   +5 more
wiley   +1 more source

The Effects of Biologic Agents on Carotid Intima‐Media Thickness and Hepatic Steatosis in Patients With Moderate‐To‐Severe Psoriasis: A Prospective Observational Cohort Study

open access: yesJEADV Clinical Practice, EarlyView.
In this prospective observational cohort study, 34 patients with moderate‐to‐severe psoriasis received biologic therapy (anti‐TNF‐α, anti‐IL‐12/23, or anti‐IL‐17) for 6 months. Carotid intima–media thickness decreased significantly in the overall cohort (p < 0.01), with the greatest reductions in the anti‐IL‐17 and anti‐IL‐12/23 groups.
Harika Ödemiş   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy